Pasithea Therapeutics Corp. (KTTAW)Miami Beach, United States | NasdaqCM
0.00 USD
+0.00
(0.000%)
⇧
(Sept. 15, 2026, 2:22 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 3:50 a.m. EDT
The immediate outlook is severely compromised by a complete absence of trading activity; the price has hit zero for the past two weeks, rendering any short-term momentum or technical entry impossible. While the balance sheet appears inflated with massive cash reserves relative to the tiny share count, the company is burning through free cash flow rapidly with no revenue, indicating a deep reliance on capital markets for survival rather than organic growth. The lack of any price history makes a long-term assessment impossible, and the business fundamentals show significant losses across the board. Furthermore, there is no dividend to provide income, leaving investors exposed to total dilution or delisting risks without any safety net. |
| Attribute | Value |
|---|---|
| Beta | 0.29 |
| Website | https://www.pasithea.com |
| Attribute | Value |
|---|---|
| Address1 | 1,111 Lincoln Road |
| Address2 | Suite 500 |
| Ask | 0.0 |
| Ask Size | 0 |
| Beta | 0.293 |
| Bid | 0.0 |
| Bid Size | 0 |
| Book Value | 1.492 |
| City | Miami Beach |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.0028 |
| Current Ratio | 26.249 |
| Custom Price Alert Confidence | HIGH |
| Day High | 0.0028 |
| Day Low | 0.0027 |
| Ebitda | -19,138,316 |
| Ebitda Margins | 0.0 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Two Week High | 0.0028 |
| Fifty Two Week High Change | 0.0 |
| Fifty Two Week High Change Percent | 0.0 |
| Fifty Two Week Low | 0.0027 |
| Fifty Two Week Low Change | 0.00009999983 |
| Fifty Two Week Low Change Percent | 0.037036974 |
| Fifty Two Week Range | 0.0027 - 0.0028 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,784,295,000,000 |
| Float Shares | 19,683,115 |
| Free Cashflow | -12,165,350 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 5 |
| Fullday Change | 0.0028 |
| Fullday Change Percent | 0.0 |
| Fullday Price | 0.0028 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Ipo Expected Date | 2,021-09-15 |
| Language | en-US |
| Long Business Summary | Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers. Its lead product candidate is PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor to treat a range of RASopathies, including neurofibromatosis type 1 (NF1); MAPK pathway-driven tumors, such as BRAFv600 and BRAF fusion tumor; and ETS2 driven diseases, including inflammatory bowel disease (IBD), primary sclerosing cholangitis, and ankylosing spondylitis. The company's lead development candidate is PAS-003, to treat amyotrophic lateral sclerosis. It also intends to develop PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida. |
| Long Name | Pasithea Therapeutics Corp. |
| Market | us_market |
| Market State | POST |
| Max Age | 86,400 |
| Message Board Id | finmb_702706441 |
| Net Income To Common | -21,291,622 |
| Open | 0.0122 |
| Operating Cashflow | -17,781,584 |
| Operating Margins | 0.0 |
| Phone | 786 977 3380 |
| Previous Close | 0.0 |
| Price Hint | 4 |
| Price To Book | 0.0018766755 |
| Profit Margins | 0.0 |
| Quick Ratio | 24.845 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0028 |
| Regular Market Change Percent | 0.0 |
| Regular Market Day High | 0.0028 |
| Regular Market Day Low | 0.0027 |
| Regular Market Day Range | 0.0027 - 0.0028 |
| Regular Market Open | 0.0122 |
| Regular Market Previous Close | 0.0 |
| Regular Market Price | 0.0028 |
| Regular Market Time | 1,789,496,577 |
| Regular Market Volume | 383 |
| Return On Assets | -0.36003 |
| Return On Equity | -0.65494 |
| Sand P52 Week Change | 0.16207206 |
| Sector | |
| Sector Key | |
| Short Name | Pasithea Therapeutics Corp. Warrant |
| Source Interval | 15 |
| State | FL |
| Symbol | KTTAW |
| Total Cash | 45,663,784 |
| Total Cash Per Share | 1.367 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | NaN |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 383 |
| Website | https://www.pasithea.com |
| Zip | 33,139 |